Fikri Avci

Has grant

Associate Professor

Emory University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Fikri Avci is an Associate Professor at Emory University School of Medicine in the United States. His research predominantly focuses on immune interactions involving glycan structures, serine-rich repeat proteins, and vaccine development against pneumococcal disease. His recent publications explore various aspects of immunology and vaccine efficacy, particularly in relation to bacterial adhesins and the design of nucleic acid vaccines.

Recent Grants

Grant: Close

Molecular Mechanisms for Carbohydrate Presentation to CD4+ T cells by MHCII Pathway

Open Date: 2016-06-06

Close Date: 2021-05-31

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Melinda Brindley

Associate Professor

University of Georgia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fikri Avci

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

The immune interactions of gut glycans and microbiota in health and disease

Erratum for Cinar et al., “Serine-rich repeat proteins: well-known yet little-understood bacterial adhesins”

Serine-rich repeat proteins: well-known yet little-understood bacterial adhesins

Emerging vaccine strategies against the incessant pneumococcal disease

Prevalence and Homology of the Pneumococcal Serine-Rich Repeat Protein at the Global Scale

Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease

Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine

Glycosylation as a key parameter in the design of nucleic acid vaccines

Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice

A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies

Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection

Characterization of the β-glucuronidase Pn3Pase as the founding member of glycoside hydrolase family GH169

Glycosyltransferases within the psrP Locus Facilitate Pneumococcal Virulence

Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens

Collaborators (1)

Melinda Brindley

Make your next move.